New Subsidiary

RNS Number : 0395P
Kanabo Group PLC
16 June 2022
 

Kanabo Group Plc.

(" Kanabo " or the "Company")

 

New Subsidiary

 

First MoU for an Indoor Medical Cannabis Production Facility in Spain

 

Kanabo Group Plc. (LON: KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, announces it has formed a new, partly owned, subsidiary to monetise the Company's Intellectual Property and that the new subsidiary has signed its first Memorandum of Understanding ("MoU") for an indoor medical cannabis cultivation project in Spain.

 

Kanabo Agritec Ltd

Kanabo Group plc has formed an Israeli subsidiary company, Kanabo Agritec Ltd. ("Agritec"), which Kanabo Research Ltd, a wholly owned subsidiary of Kanabo Group plc., holds a 40% shareholding together with certain additional control rights over the strategic direction of the subsidiary

 

Agritec's sole purpose is to enter into agreements with third parties at minimal cost to leverage the Company's Intellectual Property for the cultivation, processing, and production of cannabis products.

 

The strategic rationale for Kanabo is twofold:

· Firstly, Agritec provides Kanabo with complementary near-term revenue opportunities

· Secondly , Agritec will offer Kanabo improved security of cannabis supply through a diverse range of suppliers, who will all adopt Kanabo's high-quality manufacturing standards without Kanabo having to fund or become directly involved in cannabis cultivation.

 

Agritec's three other shareholders are co-founders Ophir Shimshi and Eilon Bdil, experts in Cannabis regulation and cultivation and R. P. Growing Technologies Ltd., who each hold 20% of the issued share capital in Agritec.

 

R.P. Growing Technologies Ltd, is a Group of companies, which includes Grow Tec Innovations Ltd (2018) & We Can Dry Ltd (2018), which are both experienced in agricultural technology projects, providing a wide range of services, from planning, designing, engineering and/or manufacturing as well as complete turnkey projects and high-level agricultural projects in field of medical Cannabis.

 

Agritec, will be able to offer customers turnkey consulting services relating to the:

· Procurement, design and build of commercial scale medical cannabis cultivation facilities

· Supply high-quality genetics and standard operating procedures for optimal medical cannabis cultivation

· Provide post-harvest services including offtake agreements with Kanabo Group plc

· Design and draft reporting and documentation filing services with the local authorities

· Provide local training and ongoing consulting services

 

First MoU for a 4,000kg Indoor Medical Cannabis Production Project in Spain

Agritec has signed its first MoU for the design, build and operation of a 4,000kg per annum indoor cultivation and processing facility in Madrid, Spain. The proposed facility is to be focused exclusively on medical cannabis.

 

As per the terms of the MoU, Agritec may may elect to receive up to 20% ownership of the Project based on the achievement of agreed milestones.



 

 

 

For further information, please visit http://www.kanabogroup.com/ or https://www.voxmarkets.co.uk/listings/LON/KNB or contact the following:

 

Kanabo Group Plc

Via Vox Markets

Avihu Tamir, CEO


Peterhouse Capital Ltd (Financial Adviser)

Tel: +44 (0)20 7469 0930

Eran Zucker / Lauren Riley


Vox Markets (Investor Relations)

KanaboGroup@voxmarkets.co.uk

Kat Perez

kperez@voxmarkets.co.uk

 

 

About Kanabo Group Plc

Kanabo Group Plc is creating a new standard in the medical cannabis industry to improve the well-being of millions of people around the world by providing a better alternative to the smoking of medicinal cannabis flowers. Kanabo, which was the first medicinal cannabis company to IPO on London Stock Exchange, has a focus on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers.

 

The Company has conducted extensive Research & Development to produce high-quality cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. Kanabo sells a range of medical cannabis products and wellness CBD products in the Primary Markets, including its VapePod, which delivers a metered dose with every inhalation.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKPBQPBKDCAD

Companies

Kanabo Group (KNB)
UK 100

Latest directors dealings